55 participants
BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-02
- Start Date:
- 2026-06-28
- Completion:
- 2027-07-31
Conditions
- Chronic Kidney Disease, Stage 4
- Chronic Kidney Disease, Stage 5
- EBV-Related Lymphoproliferative Disorder
- EBV-Related Malignant Neoplasm
- Post-Transplant Lymphoproliferative Disorder
Interventions
- PROCEDURE
- DRUG
- BIOLOGICAL
No Results Yet